Stem cell pathways contribute to clinical chemoresistance in ovarian cancer.
Steg AD, Bevis KS, Katre AA, Ziebarth A, Dobbin ZC, Alvarez RD, Zhang K, Conner M, Landen CN.
Steg AD, et al. Among authors: zhang k.
Clin Cancer Res. 2012 Feb 1;18(3):869-81. doi: 10.1158/1078-0432.CCR-11-2188. Epub 2011 Dec 5.
Clin Cancer Res. 2012.
PMID: 22142828
Free PMC article.